The planners and faculty for this activity have no relevant relationships to disclose unless listed below:

Scott Kaatz, DO, MSc, SFHM

Dr. Kaatz reports Consultant fees from Janssen, Bristol Myer Squibb, Pfizer Inc, Portola and Roche, research funding from Janssen; and Speaker Honorarium from Janssen, Boehringer Ingelheim, CSL Behring, Bristol Myers Squibb, Pfizer Inc and Daiichi Sankyo.

SHM CONFLICT OF INTEREST DISCLOSURE POLICY

In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.

Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.